EUVIMEDEUVIMED entdecken
Crossref

The impact of colchicine in preventing postpericardiotomy syndrome; a double-blind clinical trial study

Navid Reaza Mashayekhi, Alireza Alisaeedi, Alireza Rostami, Parvin Soltani

Immunopathologia Persa · 07.01.2020 · 6 (1) · e11-e11

DOI: 10.15171/ipp.2020.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunopathologia Persa, online erschienen am 07.01.2020. Verfasst von Navid Reaza Mashayekhi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Post-pericardiotomy syndrome is a relatively common complication after open heart surgery. In recent years, colchicine had a good effect on treatment of the pericarditis.

Objectives

This study aimed to study the effect of colchicine to prevent post-pericardiotomy syndrome in patients who had open heart surgery. Patients and Methods: This double-blind clinical trial study was conducted on 240 patients undergone open heart surgery. Eligible patients were selected by simple sampling and randomly divided into two groups; 120 subjects in the experimental group receive colchicine (1 mg for patients greater than 70 kg and 0.5 mg for patients lower than 70 kg) and 120 subjects in the control group who received the placebo. Patients were followed up regarding the incidence of post-pericardiotomy syndrome after the surgery during hospitalization and in follow up visits in one month and six months after hospital discharges.

Results

In total, the incidence rate of post-pericardiotomy syndrome was 33.7% (81 subjects). A significant difference of post-pericardiotomy syndrome between two groups was seen. We found post-pericardiotomy syndrome in 12.1% (29 patients) of colchicine group versus 21.6% (52 patients) in the placebo group (chi-square test). The incidence rate based on the Kaplan-Meier curve, in the second week to one month after the surgery, was lower in colchicine group while in third to the sixth month it had a constant trend.

Conclusion

Colchicine is effective for prevention the post-pericardiotomy syndrome without any life-threatening complication.

Zitieren

APA

Mashayekhi, N. R., Alisaeedi, A., Rostami, A., & Soltani, P. (2020). The impact of colchicine in preventing postpericardiotomy syndrome; a double-blind clinical trial study. Immunopathologia Persa, 6(1), e11-e11. https://doi.org/10.15171/ipp.2020.11

Vancouver

Mashayekhi NR, Alisaeedi A, Rostami A, Soltani P. The impact of colchicine in preventing postpericardiotomy syndrome; a double-blind clinical trial study. Immunopathologia Persa. 2020;6(1):e11-e11. doi:10.15171/ipp.2020.11

BibTeX
@article{Mashayekhi2020,
  author = {Mashayekhi, Navid Reaza and Alisaeedi, Alireza and Rostami, Alireza and Soltani, Parvin},
  title = {The impact of colchicine in preventing postpericardiotomy syndrome; a double-blind clinical trial study},
  journal = {Immunopathologia Persa},
  year = {2020},
  volume = {6},
  number = {1},
  pages = {e11--e11},
  doi = {10.15171/ipp.2020.11}
}
Kostenlos starten →